USPTO Examiner GIERE REBECCA M - Art Unit 1677

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17133163Device with Flow Features for Sample Processing and Method of UseDecember 2020August 2023Abandon3201NoNo
17253613METHOD FOR DETECTING BACTERIA ACCORDING TO THE GRAM SIGNAL THEREOF IN A COMPLEX SAMPLEDecember 2020June 2025Allow5410NoNo
17120798ASSAY DEVICE HAVING A WASH PORTDecember 2020February 2023Allow2600YesNo
16953601DEVICE FOR LOCATING BIOLOGICAL OBJECTSNovember 2020August 2024Allow4530YesNo
17090383METHOD AND ASSOCIATED DEVICE FOR RAPID DETECTION OF TARGET BIOMOLECULES WITH ENHANCED SENSITIVITYNovember 2020March 2023Allow2810YesNo
17067760ANALYTICAL SYSTEM COMPRISING SAMPLE MANAGEMENT MODULE AND METHOD THEREOFOctober 2020November 2023Allow3710NoNo
17035130PHOTONIC BLOOD TYPINGSeptember 2020April 2023Abandon3010NoNo
16982500COMPOSITION FOR DIAGNOSIS OF DEGENERATIVE NEUROLOGICAL DISEASESSeptember 2020March 2025Allow5421YesNo
17020628METHODS AND DEVICES FOR ACCURATE DIAGNOSIS OF INFECTIONSSeptember 2020March 2024Allow4321YesNo
16993601METHOD OF TARGET MOLECULE CHARACTERISATION USING A MOLECULAR POREAugust 2020January 2023Allow2910NoNo
16913393COATINGS WITH IMMOBILIZED AFFINITY LIGANDS AND ENZYMES AND USE THEREOF IN LIQUID CHROMATOGRAPHY ASSAYSJune 2020March 2024Allow4411YesNo
16957594A SENSOR BODY FOR BINDING AND/OR ENRICHING AND/OR DETECTING AN ANALYTE IN A SAMPLEJune 2020June 2025Allow6021NoNo
16896034Assay Device Having Controllable Sample SizeJune 2020October 2023Allow4020NoNo
16892642Methods of Producing Patient-Specific Anti-Cancer Therapeutics and Methods of Treatment ThereforJune 2020January 2024Allow4320NoNo
16758731AN INTEGRATED MICROFLUIDIC ELECTRODE ARRAY SYSTEM FOR ENZYME-LINKED IMMUNO-SORBENT ASSAY (EASY-ELISA) FOR POINT-OF-CARE DETECTION OF MOLECULAR AND CELLULAR BIOMARKERSApril 2020June 2025Abandon6031NoNo
16849811METHODS, SYSTEMS AND KITS FOR IN-PEN ASSAYSApril 2020May 2023Allow3711YesNo
16836630H-FIELD IMAGER FOR ASSAYSMarch 2020August 2023Allow4021YesNo
16650218MICROFLUIDIC DEVICE FOR GENERATING AN IN VITRO LYMPH NODEMarch 2020August 2022Allow2800NoNo
16814076DEVICE, SYSTEM, AND METHOD INCLUDING MICRO-PATTERNED CELL TREATMENT ARRAYMarch 2020December 2022Abandon3410NoNo
16645535METHOD FOR GENERATING MICRO SAMPLES AND GENERATION CHIPMarch 2020May 2025Abandon6031YesNo
16645285DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT SINGLE CELL ANALYSISMarch 2020February 2023Abandon3601NoNo
16644148NANOSENSOR METHODS AND APPARATUSES FOR DETERMINATION OF ANALYTESMarch 2020November 2024Allow5630YesNo
16807567DETECTION METHOD AND DETECTION DEVICE OF CIRCULATING TUMOR CELLMarch 2020June 2023Abandon3911NoNo
16806463NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETOMarch 2020March 2023Allow3620NoNo
16643234PARTICLE CAPTURING CHAMBER, PARTICLE CAPTURING CHIP, PARTICLE CAPTURING METHOD, APPARATUS, AND PARTICLE ANALYSIS SYSTEMFebruary 2020November 2022Abandon3301NoNo
16636795ASSAY METHODS FOR IMPROVED ANALYTE DETECTIONFebruary 2020March 2025Allow6041YesNo
16780508ENZYME QUANTIFICATIONFebruary 2020May 2023Allow3920YesNo
16751114METHODS AND DEVICES FOR INTEGRATING ANALYTE EXTRACTION, CONCENTRATION AND DETECTIONJanuary 2020December 2022Allow3410NoNo
16735604LATERAL FLOW TEST STRIP ASSAY FOR OSTEOPOROSISJanuary 2020February 2023Abandon3810NoNo
16624643BIOSENSOR FOR DETECTING A SINGLE MAGNETIC LABELDecember 2019July 2023Allow4321YesNo
16621185Homogeneous AssayDecember 2019August 2024Allow5631YesNo
16686770Multimeric Protein Purity DeterminationNovember 2019January 2024Allow5011YesNo
16614573DETECTION OF BIOMARKERS USING PLASMONIC GRATINGSNovember 2019August 2023Allow4531YesNo
16614112PARTICLE TRAPPING DEVICE AND PARTICLE TRAPPING METHODNovember 2019August 2023Allow4520NoNo
16683798MICROFLUIDIC DEVICES HAVING ISOLATION PENS AND METHODS OF TESTING BIOLOGICAL MICRO-OBJECTS WITH SAMENovember 2019July 2022Allow3210NoNo
16680278OPTICAL BIOSENSOR REFERENCING METHODNovember 2019November 2022Abandon3610NoNo
16609115AUTOMATED IMMUNOASSAY DEVICE AND METHOD USING LARGE MAGNETIC PARTICLE COMPLEXOctober 2019August 2022Allow3410YesNo
16605780THERMALLY CONTROLLED REAGENT RELEASEOctober 2019October 2022Allow3610NoNo
16500948Device and Method For The Continuous Trapping of Circulating Tumor CellsOctober 2019November 2022Abandon3811NoNo
16499254METHODS FOR THE FILTRATION OF SMALL-VOLUME HETEROGENEOUS SUSPENSIONS IN A DIGITAL MICROFLUIDIC DEVICESeptember 2019September 2023Allow4720YesNo
16492442IMMUNOCHROMATOGRAPHIC TEST PIECE FOR EXTRACTING AND MEASURING SUGAR CHAIN ANTIGEN, WHICH IS CAPABLE OF PREVENTING NON-SPECIFIC REACTIONSeptember 2019February 2024Allow5321YesNo
16543512Microfluidic System and Method for Real-Time Measurement of Antibody-Antigen Binding and Analyte DetectionAugust 2019October 2023Allow5021YesNo
16468357Measuring System and Manufacturing Process of Such a Measuring SystemJune 2019November 2022Allow4120YesNo
16430037METHOD FOR DETECTING COLIFORM BACTERIA CONTAINED IN MILKJune 2019November 2022Allow4110NoNo
16461480Multiplex Hybrid Microfluidics Analyte Detection SystemsMay 2019October 2022Abandon4111NoNo
16340853METHOD FOR ENHANCING THE INCUBATION OF SAMPLES, SPECIMENS AND REAGENTS USING LASERSApril 2019February 2023Abandon4621NoNo
16326363BLOOD UNIT TESTS KITFebruary 2019October 2022Allow4430YesNo
16137150SYSTEM AND METHOD FOR MEDICAL ESCALATION AND INTERVENTION THAT IS A DIRECT RESULT OF A REMOTE DIAGNOSTIC TESTSeptember 2018January 2024Allow6051NoNo
16070368Micro-fluidic device for selective sorting of highly motile and morphologically normal sperm from unprocessed semenJuly 2018November 2022Allow5210YesNo
15802989ULTRA-FAST PATHOGEN TOXIN DETECTION ASSAY BASED ON MICROWAVE-ACCELERATED METAL-ENHANCED FLUORESCENCENovember 2017May 2018Allow600YesNo
15787991REAGENT ZONE DEPOSITION PATTERNOctober 2017January 2018Allow300NoNo
15787638METHODS AND DEVICES FOR INTEGRATING ANALYTE EXTRACTION, CONCENTRATION AND DETECTIONOctober 2017February 2018Allow400YesNo
15696469Sieve Valves, Microfluidic Circuits, Microfluidic Devices, Kits, and Methods for Isolating an AnalyteSeptember 2017April 2018Allow700YesNo
15671422MICROWELL ARRAY ARTICLES AND METHODS OF USEAugust 2017September 2017Allow100NoNo
15667568BIOMOLECULE ISOLATIONAugust 2017August 2018Allow1210NoNo
15652665Nanodiamond countingJuly 2017November 2017Allow400NoNo
15618225ROTATABLE FLUID SAMPLE COLLECTION DEVICEJune 2017April 2018Allow1000NoNo
15616740SYSTEM AND METHOD FOR DETECTING COMPONENTS OF A MIXTURE INCLUDING A VALVING SCHEME FOR COMPETITION ASSAYSJune 2017July 2017Allow100NoNo
15615568MICRO-DEVICES FOR IMPROVED DISEASE DETECTIONJune 2017June 2018Allow1310NoNo
15611527Suspension Container for Binding Particles for the Isolation of Biological MaterialJune 2017November 2017Allow600YesNo
15493273DEVICE, SYSTEM, AND METHOD INCLUDING MICRO-PATTERNED CELL TREATMENT ARRAYApril 2017December 2017Allow800YesNo
15443426FLOW CONTROL IN MICROFLUIDIC SYSTEMSFebruary 2017August 2017Allow610NoNo
15436585PHOTONIC BLOOD TYPINGFebruary 2017May 2018Allow1510YesNo
15392412METHODS FOR DETECTING A BIOMARKER BY ALTERNATING CURRENT ELECTROKINETICSDecember 2016March 2017Allow200NoNo
15228491SIGNAL AMPLIFICATION IN SOLUTION-BASED PLASMONIC SPECIFIC-BINDING PARTNER ASSAYSAugust 2016July 2017Allow1210NoNo
15212636Method For Using Nanodiamonds To Detect Nearby Magnetic NanoparticlesJuly 2016December 2016Allow410YesNo
15209616CONVOLUTIONAL NEURAL NETWORKS FOR CANCER DIAGNOSISJuly 2016April 2017Allow920YesNo
15172096MICROFABRICATED QLIDA BIOSENSORS WITH AN EMBEDDED HEATING AND MIXING ELEMENTJune 2016July 2018Abandon2610NoNo
15087684SIEVE VALVES, MICROFLUIDIC CIRCUITS, MICROFLUIDIC DEVICES, KITS, AND METHODS FOR ISOLATING AN ANALYTEMarch 2016May 2017Allow1411YesNo
15073518SAMPLE ANALYSIS SYSTEMS AND METHODSMarch 2016April 2018Allow2511YesNo
15066426METHODS OF AND DEVICES FOR CAPTURING CIRCULATING TUMOR CELLSMarch 2016October 2016Abandon810NoNo
15001589CELL ANALYSIS BY MASS CYTOMETRYJanuary 2016May 2016Allow300NoNo
14976318MAGNETIC IMMUNOSENSOR AND METHOD OF USEDecember 2015January 2018Allow2500YesNo
14923289CELL SORTER SYSTEM AND METHODOctober 2015June 2016Allow801YesNo
14878760FILTRATION DEVICE FOR ASSAYSOctober 2015July 2018Abandon3310NoNo
14877411MICROWELL ARRAY ARTICLES AND METHODS OF USEOctober 2015June 2017Allow2020NoYes
14869718DEVICE AND METHOD OF DETECTING TSHSeptember 2015March 2018Allow3001NoNo
14775860APPARATUS AND METHOD FOR DETECTING AND COUNTING RARE CELLS IN BLOODSeptember 2015April 2018Allow3110YesNo
14851883DEVICES, METHODS, AND KITS FOR DETECTING AN ANALYTE IN A SAMPLESeptember 2015April 2018Allow3121YesNo
14774658PLASMONIC SUBSTRATE FOR MULTIPLEX ASSESSMENT OF TYPE 1 DIABETESSeptember 2015May 2018Abandon3301NoNo
14828238METHOD AND APPARATUS FOR SORTING PARTICLESAugust 2015January 2016Allow510YesNo
14819893LATERAL FLOW ASSAY DEVICEAugust 2015May 2018Allow3321NoNo
14814808SPECIMEN MEASUREMENT APPARATUS AND SPECIMEN MEASUREMENT METHODJuly 2015October 2017Allow2621YesNo
14808939Reconfigurable microfluidic systems: Scalable, multiplexed immunoassaysJuly 2015June 2017Allow2310YesNo
14798103Microfluidic Devices and Methods for Separating and Detecting Constituents in a Fluid SampleJuly 2015July 2016Allow1200YesNo
14793538KITS AND METHODS FOR CYANIDE DETECTIONJuly 2015September 2016Allow1410NoNo
14737195BIOSENSOR HAVING DECOUPLED CAPTURE CHAMBER AND DETECTION CHAMBER, USING PARTICLE AGGREGATION AND SIZE-SEPARATIONJune 2015January 2018Allow3111NoNo
14649646Reference and Normalisation Method for Use With Bead-Based Immunoassays in a Microfluidic DiscJune 2015October 2017Abandon2801NoNo
14722510SENSING DEVICE, AND SENSING SYSTEM AND SENSING METHOD USING THE SAMEMay 2015March 2018Allow3320NoNo
14703120SELF-LOADING MICROFLUIDIC DEVICE AND METHODS OF USEMay 2015February 2017Allow2210YesNo
14434312CENTRIPETAL MICROFLUIDIC PLATFORM FOR LALREACTIVE SUBSTANCES TESTINGApril 2015May 2018Allow3711YesNo
14669801ANALYZER AND IMMUNOASSAY METHODMarch 2015September 2017Allow3011NoNo
14669840SAMPLE ANALYZER AND SAMPLE ANALYZING METHODMarch 2015October 2017Allow3101NoNo
14667249SENSOR CHIP, DETECTION SYSTEM, AND METHOD OF DETECTING TARGET SUBSTANCE IN ANALYTEMarch 2015February 2017Allow2311NoNo
14642487AUTOMATED BLOTTING USING SLIDING DEVICESMarch 2015October 2017Allow3111NoNo
14425128A SENSOR DEVICE AND A METHOD OF SAMPLINGMarch 2015May 2017Allow2711NoNo
14641022METHODS AND DEVICES FOR INTEGRATING ANALYTE EXTRACTION, CONCENTRATION AND DETECTIONMarch 2015July 2017Allow2811NoNo
14634209LATERAL FLOW BLOTTING ASSAYFebruary 2015February 2017Allow2311YesNo
14617372SUSPENSION CONTAINER FOR BINDING PARTICLES FOR THE ISOLATION OF BIOLOGICAL MATERIALFebruary 2015February 2017Allow2520NoNo
14417038DISPOSABLE TEST DEVICEJanuary 2015June 2017Abandon2901NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GIERE, REBECCA M.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
1.4%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
11
Allowed After Appeal Filing
3
(27.3%)
Not Allowed After Appeal Filing
8
(72.7%)
Filing Benefit Percentile
40.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 27.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner GIERE, REBECCA M - Prosecution Strategy Guide

Executive Summary

Examiner GIERE, REBECCA M works in Art Unit 1677 and has examined 292 patent applications in our dataset. With an allowance rate of 70.2%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner GIERE, REBECCA M's allowance rate of 70.2% places them in the 34% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GIERE, REBECCA M receive 1.88 office actions before reaching final disposition. This places the examiner in the 41% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GIERE, REBECCA M is 34 months. This places the examiner in the 42% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +37.4% benefit to allowance rate for applications examined by GIERE, REBECCA M. This interview benefit is in the 84% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 30.8% of applications are subsequently allowed. This success rate is in the 64% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 26.7% of cases where such amendments are filed. This entry rate is in the 38% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 88.9% of appeals filed. This is in the 82% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 68.4% are granted (fully or in part). This grant rate is in the 74% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.3% of allowed cases (in the 55% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.9% of allowed cases (in the 82% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.